Found: 21
Select item for more details and to access through your institution.
Establishment and Characterization of a Cell Line (S-RMS1) Derived from an Infantile Spindle Cell Rhabdomyosarcoma with SRF-NCOA2 Fusion Transcript.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 11, p. 5484, doi. 10.3390/ijms22115484
- By:
- Publication type:
- Article
DNA Methylation Profiling for Diagnosing Undifferentiated Sarcoma with Capicua Transcriptional Receptor (CIC) Alterations.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 5, p. 1818, doi. 10.3390/ijms21051818
- By:
- Publication type:
- Article
FGFR1 is a potential therapeutic target in neuroblastoma.
- Published in:
- Cancer Cell International, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12935-022-02587-x
- By:
- Publication type:
- Article
ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism.
- Published in:
- Genome Biology, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s13059-021-02271-9
- By:
- Publication type:
- Article
CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue Sarcomas.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.01230
- By:
- Publication type:
- Article
Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00957
- By:
- Publication type:
- Article
PI3K/Akt Pathway: The Indestructible Role of a Vintage Target as a Support to the Most Recent Immunotherapeutic Approaches.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4040, doi. 10.3390/cancers13164040
- By:
- Publication type:
- Article
Crosstalk between Macrophages and Myxoid Liposarcoma Cells Increases Spreading and Invasiveness of Tumor Cells.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3298, doi. 10.3390/cancers13133298
- By:
- Publication type:
- Article
PD‐1‐induced T cell exhaustion is controlled by a Drp1‐dependent mechanism.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 1, p. 188, doi. 10.1002/1878-0261.13103
- By:
- Publication type:
- Article
The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1142597
- By:
- Publication type:
- Article
TMOD-14. INNOVATIVE 3D MODEL FOR THE ESTABLISHMENT OF PRIMARY PAEDIATRIC LOW-GRADE GLIOMA (LGG) CULTURES: NEW PLATFORM FOR ADVANCED PRECLINICAL STUDIES OF INNOVATIVE AND IMMUNOTHERAPEUTIC APPROACHES.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii123, doi. 10.1093/neuonc/noz036.251
- By:
- Publication type:
- Article
IMMU-12. NOVEL APPROACH FOR THE TREATMENT OF PEDIATRIC HIGH-GRADE GLIOMAS WITH THE COMBINATION OF ONCOLYTIC ADENOVIRUSES AND GENE THERAPY ENCODING A BiTE DIRECTED TO THE EphA2 TUMOR ANTIGEN.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii95, doi. 10.1093/neuonc/noz036.133
- By:
- Publication type:
- Article
Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell Malignancies.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.755639
- By:
- Publication type:
- Article
Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.634031
- By:
- Publication type:
- Article
Identification of New Soluble Factors Correlated With the Development of Graft Failure After Haploidentical Hematopoietic Stem Cell Transplantation.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.613644
- By:
- Publication type:
- Article
Nanoparticles for Diagnosis and Target Therapy in Pediatric Brain Cancers.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 1, p. 173, doi. 10.3390/diagnostics12010173
- By:
- Publication type:
- Article
Manipulating the Metabolism to Improve the Efficacy of CAR T-Cell Immunotherapy.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 1, p. 14, doi. 10.3390/cells10010014
- By:
- Publication type:
- Article
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01376-3
- By:
- Publication type:
- Article
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01376-3
- By:
- Publication type:
- Article
Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01193-0
- By:
- Publication type:
- Article
Corrigendum: Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice